Ipamorelin, also known as NNC 26-0161, serves as a selective growth hormone-releasing hormone (GHRH) agonist. This synthetic peptide resembles the effects of naturally occurring GHRH, stimulating the pituitary gland to secrete growth hormone (GH). Ipamorelin displays a high affinity for the GHRH receptor and has minimal side effects compared to oth